Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation
暂无分享,去创建一个
H. Rüden | M. Dettenkofer | R. Babikir | F. Daschner | J. Finke | U. Frank | H. Bertz | W. Ebner | M. Dettenkofer
[1] P Gastmeier,et al. Surveillance of nosocomial infections , 2004 .
[2] Nnis System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.
[3] H. Rüden,et al. Surveillance of nosocomial infections in a neurology intensive care unit , 2001, Journal of Neurology.
[4] R. Ramphal,et al. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] C. Dykewicz. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] P. Moreau,et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] F. Locatelli,et al. Incidence of, and Risk Factors for, Nosocomial Infections Among Hematopoietic Stem Cell Transplantation Recipients, With Impact on Procedure-Related Mortality , 2001, Infection Control & Hospital Epidemiology.
[8] A. Gratwohl,et al. Hematopoietic stem cell transplantation activity in Europe 1999 , 2001, Bone Marrow Transplantation.
[9] L. Elting,et al. Adenovirus infections in adult recipients of blood and marrow transplants. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] I. Flinn,et al. New approaches to treating malignances with stem cell transplantation. , 2000, Seminars in oncology.
[11] D. Milligan,et al. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality , 2000, Bone Marrow Transplantation.
[12] A. Keating,et al. Overview of autologous stem cell transplantation. , 2000, Critical reviews in oncology/hematology.
[13] D. Hailey,et al. ALLOGENEIC STEM CELL TRANSPLANTATION , 2000, International Journal of Technology Assessment in Health Care.
[14] H. Rüden,et al. How to Survey Nosocomial Infections , 2000, Infection Control & Hospital Epidemiology.
[15] R. Champlin,et al. Control of Nosocomial Clostridium difficile Transmission in Bone Marrow Transplant Patients , 2000, Infection Control & Hospital Epidemiology.
[16] J. Klausner,et al. Outbreak of Stenotrophomonas maltophilia Bacteremia Among Patients Undergoing Bone Marrow Transplantation: Association With Faulty Replacement of Handwashing Soap , 1999, Infection Control & Hospital Epidemiology.
[17] T. Perl,et al. An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] N. Kröger,et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation – a 7 year single centre investigation of 409 cases , 1999, Bone Marrow Transplantation.
[19] J. Cornish,et al. Infections in adults undergoing unrelated donor bone marrow transplantation , 1999, British journal of haematology.
[20] L. To,et al. Peripheral Stem Cells in Bone Marrow Transplantation. Future prospects. , 1999, Bailliere's best practice & research. Clinical haematology.
[21] P. Ljungman,et al. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection , 1998, Bone Marrow Transplantation.
[22] R. Liang,et al. Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment , 1998, Bone Marrow Transplantation.
[23] H. Sakamaki,et al. Utility and safety of Hickman catheters for venous access after bone marrow transplantation. , 1998, Internal medicine.
[24] D. Engelhard,et al. Nosocomial Colonization, Septicemia, and Ilickman/Broviac Catheter‐Related Infections in Bone Marrow Transplant Recipients: A 5‐Year Prospective Study , 1998, Medicine.
[25] E. Jantunen,et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients , 1997, Bone Marrow Transplantation.
[26] N. Woodford,et al. Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit. , 1996, The Journal of hospital infection.
[27] I. Lossos,et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. , 1995, Transplantation.
[28] A. Hunter,et al. Bone marrow transplantation: current situation, complications and prevention. , 1995, The Journal of antimicrobial chemotherapy.
[29] A. Emmerson. The impact of surveys on hospital infection. , 1995, The Journal of hospital infection.
[30] B. Farr,et al. Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters , 1995, Cancer.
[31] P. Wiernik,et al. Nosocomial Infections in Neutropenic Cancer Patients , 1993, Infection Control & Hospital Epidemiology.
[32] E. Baráth,et al. Fundamentals of Biostatistics. , 1992 .
[33] J M Hughes,et al. CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.
[34] R. Haley,et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. , 1985, American journal of epidemiology.
[35] V Kestnerová,et al. [Surveillance of nosocomial infections. I (author's transl)]. , 1975, Ceskoslovenska epidemiologie, mikrobiologie, imunologie.
[36] National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000. , 2000, American journal of infection control.
[37] R. Vij,et al. Innovations in allogeneic stem-cell transplantation. , 2000, Seminars in hematology.
[38] G. Morgan,et al. Bone marrow and peripheral blood stem cell transplantation for malignancy. , 1998, Health technology assessment.
[39] C. Huber,et al. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation , 1997, Bone Marrow Transplantation.
[40] R. Wenzel,et al. Prevention and Control of Nosocomial Infections , 1997 .
[41] CDC definitions for nosocomial infections, 1988. , 1989, The American review of respiratory disease.